Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

 ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve 1. The Unaudited Standalone & Consolidated Financial Results along with Limited Review Report thereon for the Quarter and Nine Months ended 31st December, 2023. 2. Transact any other matter, if any with permission of chairman.
07-02-2024
Bigul

ANG Lifesciences India Ltd - 540694 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015.

 In reference to our letter dated 31.01.2024, ANG/23-24/BSE-149, please find herewith enclosed the additional details as per SEBI circular no. CIR/CFD/CMD/4/2015 dated Sept. 09, 2015 for amendment in the previous agreement for Assets Purchase agreement with Ind-Swift Ltd (14.08.2021)
01-02-2024
Bigul

ANG Lifesciences India Ltd - 540694 - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (The 'Listing Regulations')

 We hereby inform you that with mutual agreement between ANG and Ind-Swift Ltd, the previous Assets Purchase agreement dated 14.08.2021 has been amended and now ANG acquired only Unit III of Ind swift Ltd.
31-01-2024
Bigul

ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed the confirmation certificate under Reg 74(5) of SEBI PIT Reg. 2018 for quarter ended as on 31.12.2023
15-01-2024
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

 M/s Singh Bhupinder & Associates, Chartered Accounant is apointed as Statutory Auditor with subject to the Shareholders'' approval
30-12-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

 Intimation of Closure of Trading Window
30-12-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

 Closure of Tradinhg window from 01.01.2024 for the insider, designated persons of the company and their immeditae relatives, till the end of 48 hours after the declaration of unaudited standalone and consolidated financial result for quarter and nine month result ended as at 31.12.2023
30-12-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

 Closure of Trading window for insider and designated persons and their immediate relatives from 01st January 2024 to 48 hrs. till the end of declaration of quarter and nine months standalone and consolidated financial result ended as at 31.12.2023
30-12-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

 Closure of Trading window from 01st January 2024 for the insider and designated person of the company and their immediate relatives, till the end of 48 hours after the declaration of unaudited Standalone & Consolidated financial result for the quarter and nine months ended as at 31.12.2023
30-12-2023

ANG Lifescience Standalone September 2023 Net Sales at Rs 29.58 crore, down 49.35% Y-o-Y
16-11-2023
Next Page
Close

Let's Open Free Demat Account